The 340B Drug Pricing Program was created to help certain healthcare organizations stretch their limited resources to provide more services and reach more patients. Unfortunately, the 340B program has become a profit driver for hospitals and other entities that markup discounted drugs to boost profits, while patients struggle to afford care.
The Infusion Access Foundation is a member of the AIR340B Coalition, a coalition of organizations dedicated to ensuring the 340B program directly supports access to treatment for uninsured vulnerable patients. To learn more about 340B reform, please visit the AIR340B Coalition's website.